Wall Street analysts expect Universal Health Services, Inc. (NYSE:UHS) to report sales of $2.63 billion for the current quarter, according to Zacks Investment Research. Five analysts have provided estimates for Universal Health Services’ earnings. The highest sales estimate is $2.64 billion and the lowest is $2.60 billion. Universal Health Services posted sales of $2.48 billion during the same quarter last year, which would indicate a positive year over year growth rate of 6%. The firm is expected to announce its next earnings report on Tuesday, February 27th.
According to Zacks, analysts expect that Universal Health Services will report full year sales of $2.63 billion for the current year, with estimates ranging from $10.37 billion to $10.41 billion. For the next financial year, analysts forecast that the business will report sales of $10.90 billion per share, with estimates ranging from $10.82 billion to $10.97 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side analysts that cover Universal Health Services.
Several equities research analysts recently issued reports on the company. Zacks Investment Research raised Universal Health Services from a “hold” rating to a “buy” rating and set a $135.00 price objective for the company in a research note on Wednesday. Wells Fargo & Co reaffirmed an “outperform” rating and set a $144.00 price target on shares of Universal Health Services in a research note on Tuesday, January 30th. Mizuho set a $137.00 price target on Universal Health Services and gave the stock a “buy” rating in a research note on Wednesday, January 24th. Royal Bank of Canada reaffirmed a “buy” rating and set a $134.00 price target on shares of Universal Health Services in a research note on Thursday, January 4th. Finally, Goldman Sachs Group began coverage on Universal Health Services in a research note on Wednesday, January 3rd. They set a “buy” rating and a $137.00 price target for the company. One analyst has rated the stock with a sell rating, three have given a hold rating and thirteen have assigned a buy rating to the company. Universal Health Services presently has an average rating of “Buy” and an average price target of $131.20.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 15th. Stockholders of record on Thursday, March 1st will be issued a $0.10 dividend. The ex-dividend date is Wednesday, February 28th. This represents a $0.40 annualized dividend and a dividend yield of 0.34%. Universal Health Services’s dividend payout ratio is currently 5.49%.
Universal Health Services declared that its board has approved a stock buyback program on Wednesday, November 15th that authorizes the company to repurchase $400.00 million in outstanding shares. This repurchase authorization authorizes the health services provider to buy shares of its stock through open market purchases. Stock repurchase programs are typically an indication that the company’s management believes its shares are undervalued.
Several institutional investors and hedge funds have recently added to or reduced their stakes in UHS. Orbimed Advisors LLC purchased a new position in shares of Universal Health Services in the third quarter worth about $74,219,000. Jana Partners LLC increased its holdings in shares of Universal Health Services by 39.1% in the third quarter. Jana Partners LLC now owns 1,891,986 shares of the health services provider’s stock worth $209,897,000 after buying an additional 531,358 shares during the period. Nordea Investment Management AB increased its holdings in shares of Universal Health Services by 8,502.1% in the third quarter. Nordea Investment Management AB now owns 318,706 shares of the health services provider’s stock worth $35,357,000 after buying an additional 315,001 shares during the period. Wedge Capital Management L L P NC increased its holdings in shares of Universal Health Services by 17.7% in the fourth quarter. Wedge Capital Management L L P NC now owns 1,844,034 shares of the health services provider’s stock worth $209,021,000 after buying an additional 277,116 shares during the period. Finally, Glenview Capital Management LLC increased its holdings in shares of Universal Health Services by 15.1% in the second quarter. Glenview Capital Management LLC now owns 1,973,545 shares of the health services provider’s stock worth $240,930,000 after buying an additional 259,081 shares during the period. Hedge funds and other institutional investors own 86.11% of the company’s stock.
WARNING: “$2.63 Billion in Sales Expected for Universal Health Services, Inc. (UHS) This Quarter” was originally published by American Banking News and is the property of of American Banking News. If you are viewing this report on another website, it was illegally copied and republished in violation of U.S. and international copyright law. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/02/04/2-63-billion-in-sales-expected-for-universal-health-services-inc-uhs-this-quarter-2.html.
About Universal Health Services
Universal Health Services, Inc is a holding company. The Company’s principal business is owning and operating, through its subsidiaries, acute care hospitals and outpatient facilities, and behavioral healthcare facilities. The Company’s segments include Acute Care Hospital Services, Behavioral Health Services and Other.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.